HNO Praxis Dresden Dr. med. Udo Schäfer

At HNO Praxis Dresden Dr. med. Udo Schäfer in Dresden, clinical research focuses strongly on allergic rhinitis and rhinoconjunctivitis, especially conditions triggered by birch pollen, grass pollen, and house dust mite exposure. These studies aim to evaluate new and established immunotherapy approaches and improve symptom control for people with seasonal and perennial allergies.

• Trials in birch pollen-induced allergic rhinitis and allergic rhinoconjunctivitis are testing whether treatment can reduce symptoms and the need for rescue medication.
• Several studies in house dust mite allergy and related allergic airway disease are examining how well immunotherapy improves daily allergy burden.
• Research also includes grass pollen allergy, with a focus on better long-term control of seasonal nasal and eye symptoms.

Overall, this site contributes to improving allergy treatment effectiveness and patient comfort through studies that compare active therapies with placebo and assess real-world symptom relief.

The site is also involved in research on ear, nose, and throat conditions, particularly chronic rhinosinusitis with nasal polyps. These trials are designed to better understand persistent nasal blockage, inflammation, and polyp-related symptoms, while evaluating new treatment options that may improve quality of life for affected adults.

• Studies in chronic rhinosinusitis with nasal polyps are assessing whether emerging therapies can reduce nasal congestion and polyp severity.
• Participant experience research is exploring how people perceive symptom changes and treatment satisfaction during CRSwNP care.
• This work supports the development of more effective options for difficult-to-treat nasal inflammatory disease.

The research at this health care site reflects a clear interest in advancing care for chronic upper-airway disorders, with emphasis on meaningful symptom improvement and better disease control.

Clinical trials here also address respiratory tract diseases linked to allergy, especially patients whose nasal symptoms may occur alongside asthma or broader airway inflammation. The research aims to refine treatment strategies for people with moderate to severe disease and to identify therapies that are both effective and well tolerated.

• Trials in moderate to severe allergic rhinitis with or without asthma are evaluating how well treatment reduces combined symptom and medication burden.
• Studies of subcutaneous and sublingual immunotherapy are testing different ways to improve control of pollen- and mite-driven respiratory allergy.
• Research is aimed at establishing the best balance between symptom relief, tolerability, and overall treatment benefit.

With a strong concentration on allergic respiratory conditions, the site contributes to research that may help patients manage both seasonal and year-round symptoms more effectively.